保齡寶(002286.SZ):與包括元氣森林在內的許多飲品公司及新式茶飲品牌進行了業務合作
格隆匯9月12日丨保齡寶(002286.SZ)於2024年9月10日接受特定對象調研,就“與元氣森林合作情況,如何看待新式茶飲”,公司表示,公司與包括元氣森林在內的許多飲品公司及新式茶飲品牌進行了業務合作,包括赤蘚糖醇、聚葡萄糖、抗性糊精及低聚糖等多種產品,同時公司還向眾多飲品公司提供產品配方相關建議。許多新式茶飲品牌,已經開始在產品中使用代糖,以提供無糖或低糖的飲品選項,吸引注重健康的消費者。無糖飲料的市場滲透率逐漸提高,預計未來將有更多新式茶飲品牌推出含代糖的產品,以適應這一趨勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.